Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 189

    1.

    Breast cancer histological classification: agreement between the Office for National Statistics and the National Health Service Breast Screening Programme.

    Gathani T, Bull D, Green J, Reeves G, Beral V; Million Women Study Collaborators.

    Breast Cancer Res. 2005;7(6):R1090-6. Epub 2005 Nov 9.

    PMID:
    16457689
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    The Scottish breast screening programme's experience of monitoring interval cancers.

    Everington D, Gilbert FJ, Tyack C, Warner J.

    J Med Screen. 1999;6(1):21-7.

    PMID:
    10321366
    [PubMed - indexed for MEDLINE]
    3.

    Comparison of prognostic and socio-economic factors in screen-detected and symptomatic cases of breast cancer.

    Garvican L, Littlejohns P.

    Public Health. 1998 Jan;112(1):15-20.

    PMID:
    9490883
    [PubMed - indexed for MEDLINE]
    6.

    Results from the UK NHS Breast Screening Programme 2000-05.

    Bennett RL, Blanks RG, Patnick J, Moss SM.

    J Med Screen. 2007;14(4):200-4.

    PMID:
    18078565
    [PubMed - indexed for MEDLINE]
    7.

    The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group.

    [No authors listed]

    Breast Cancer Res. 1999;1(1):73-80. Epub 1999 Aug 19.

    PMID:
    11056681
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    NHSBSP type 1 interval cancers: a scientifically valid grouping?

    Porter GJ, Evans AJ, Burrell HC, Lee AH, Chakrabarti J.

    Clin Radiol. 2007 Mar;62(3):262-7.

    PMID:
    17293220
    [PubMed - indexed for MEDLINE]
    9.

    Interval breast cancers in the NHS Breast Screening Programme: does the current definition exclude too many?

    Faux AM, Richardson DC, Lawrence GM, Wheaton ME, Wallis MG.

    J Med Screen. 1997;4(3):169-73.

    PMID:
    9368875
    [PubMed - indexed for MEDLINE]
    10.

    Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study.

    Longacre TA, Ennis M, Quenneville LA, Bane AL, Bleiweiss IJ, Carter BA, Catelano E, Hendrickson MR, Hibshoosh H, Layfield LJ, Memeo L, Wu H, O'malley FP.

    Mod Pathol. 2006 Feb;19(2):195-207.

    PMID:
    16341153
    [PubMed - indexed for MEDLINE]
    Free Article
    11.

    Slippage in the NHS breast screening programme: an assessment of whether a three year screening round is being achieved.

    Faux AM, Lawrence GM, Wheaton ME, Wallis MG, Jeffery CL, Griffiths RK.

    J Med Screen. 1998;5(2):88-91.

    PMID:
    9718527
    [PubMed - indexed for MEDLINE]
    12.

    The National Health Service Breast Screening Programme and British Association of Surgical Oncology audit of quality assurance in breast screening 1996-2001.

    Sauven P, Bishop H, Patnick J, Walton J, Wheeler E, Lawrence G; National Health Service Breast Screening Programme; British Association of Surgical Oncology.

    Br J Surg. 2003 Jan;90(1):82-7.

    PMID:
    12520580
    [PubMed - indexed for MEDLINE]
    14.

    Routine breast screening for women aged 65-69: results from evaluation of the demonstration sites.

    Moss SM, Brown J, Garvican L, Coleman DA, Johns LE, Blanks RG, Rubin G, Oswald J, Page A, Evans A, Gamble P, Wilson R, Lee L, Liston J, Sturdy L, Sutton G, Wardman G, Patnick J, Winder R.

    Br J Cancer. 2001 Nov 2;85(9):1289-94.

    PMID:
    11720462
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    The clinical and pathological differences in prevalent round screen-detected and symptomatic invasive breast cancer.

    Sweeney KJ, Kell MR, Aziz NA, Prunty N, Holloway P, Kennedy M, Flanagan F, Kerin MJ.

    Ir Med J. 2007 Sep;100(8):550-2.

    PMID:
    17955686
    [PubMed - indexed for MEDLINE]
    16.

    What is the impact of breast augmentation on the Breast Screening Programme?

    Colville RJ, Mallen CA, McLean L, McLean NR.

    Eur J Surg Oncol. 2003 Jun;29(5):434-6.

    PMID:
    12798746
    [PubMed - indexed for MEDLINE]
    17.

    Impact of a national external quality assessment scheme for breast pathology in the UK.

    Ellis IO, Coleman D, Wells C, Kodikara S, Paish EM, Moss S, Al-Sam S, Anderson N, Bobrow L, Buley I, Connolly CE, Dallimore NS, Hales S, Hanby A, Humphreys S, Knox F, Lowe J, Macartney J, Nash R, Parham D, Patnick J, Pinder SE, Quinn CM, Robertson AJ, Shrimankar J, Walker RA, Winder R.

    J Clin Pathol. 2006 Feb;59(2):138-45.

    PMID:
    16443727
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Use of a cancer register for monitoring and evaluating a breast cancer screening programme.

    Bull A, Mountney L, Sanderson H.

    Community Med. 1989 Aug;11(3):220-4.

    PMID:
    2605888
    [PubMed - indexed for MEDLINE]
    19.

    Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data.

    Vinnicombe S, Pinto Pereira SM, McCormack VA, Shiel S, Perry N, Dos Santos Silva IM.

    Radiology. 2009 May;251(2):347-58. Review.

    PMID:
    19401569
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Can the NHS Breast Screening Programme afford not to double read screening mammograms?

    Liston JC, Dall BJ.

    Clin Radiol. 2003 Jun;58(6):474-7.

    PMID:
    12788317
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk